PARALLELE BIOSCIENCE
Angel Dough Ventures is a startup accelerator that identifies new business ideas as well as develops and launches new products and services into the market. It also reviews customer feedback and analyzes metrics to transform and improve its businesses. Angel Dough Ventures was founded by Andrew Hazen and is headquartered in Hicksville, New York.
PARALLELE BIOSCIENCE
Industry:
Biotechnology Business Intelligence
Founded:
2000-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M USD
Technology used in webpage:
SPF SSL By Default Apple Mobile Web Clips Icon Font Awesome Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA
Founder
Investors List
Versant Ventures
Versant Ventures investment in Convertible Note - ParAllele Bioscience
Index Ventures
Index Ventures investment in Convertible Note - ParAllele Bioscience
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Convertible Note - ParAllele Bioscience
Abingworth
Abingworth investment in Convertible Note - ParAllele Bioscience
Mohr Davidow Ventures
Mohr Davidow Ventures investment in Series B - ParAllele Bioscience
Index Ventures
Index Ventures investment in Series B - ParAllele Bioscience
Abingworth
Abingworth investment in Series B - ParAllele Bioscience
Versant Ventures
Versant Ventures investment in Series B - ParAllele Bioscience
Versant Ventures
Versant Ventures investment in Series A - ParAllele Bioscience
Abingworth
Abingworth investment in Series A - ParAllele Bioscience
More informations about "ParAllele Bioscience"
ParAllele Bioscience 2025 Company Profile: Valuation, Investors ...
The current revenue for ParAllele Bioscience is . How much funding has ParAllele Bioscience raised over time? ParAllele Bioscience has raised $22.3M. Who are ParAllele Bioscienceโs โฆSee details»
ParAllele Bioscience - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 14, 2005: Convertible Note โฆSee details»
ParAllele Bioscience - VentureRadar
ParAllele BioScience is developing techniques for carrying out massively parallel PCR. This can be applied towards SNP genotyping, mRNA profiling and other high throughput genomic โฆSee details»
ParAllele BioScience - Ownership and Business Overview - Mergr
May 31, 2005 ParAllele BioScience was founded in 2000. Life Science M&A Summary in 2005 Out of 60 sectors in the Mergr database, life science ranked 14 in number of deals in 2005 .See details»
Parallele Bioscience Inc - Company Profile and News
Company profile page for Parallele Bioscience Inc including stock price, company news, executives, board members, and contact informationSee details»
ParAllele BioScience - Company Profile - Tracxn
Mar 5, 2025 ParAllele BioScience - Assay-based genetic discovery solutions to the life science research, pharmaceutical, and diagnostic sectors. Acquired by Affymetrix. Raised a total โฆSee details»
ParAllele Bioscience - Updates, News, Events, Signals & Triggers
ParAllele Bioscience enables highly multiplexed SNP identification and discovery. It has been acquired by Affymetrix.See details»
ParAllele BioScience, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore ParAllele BioScience, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 6 literature.See details»
Parallele Bioscience
ParAllele Bioscience enables highly multiplexed SNP identification and discovery. The technology delivers higher throughput at a lower cost and requires lower sample quantities than โฆSee details»
ParAllele BioScience - Products, Competitors, Financials, โฆ
Headquarters Location. 7300 Shoreline Court . South San Francisco, California, 94080, United States. 650-228-7400See details»
ParAllele BioScience Company Profile | Management and
Find contact information for ParAllele BioScience. Learn about their Business Services, Research & Development market share, competitors, and ParAllele BioScience's email format.See details»
ParAllele BioScience Inc.
Oct 1, 2003 Armed with a technology that enables a complete genomics analysis of a blood sample, ParAllele BioScience aims to drive down the cost of discovery of genetic mutations by โฆSee details»
ParAllele BioScience, Inc.:Company Profile & Technical Research ...
ParAllele BioScience, Inc. is a company that provides Metrics and more. ParAllele BioScience, Inc. is headquartered in United States Massachusetts. ParAllele BioScience, Inc. was founded โฆSee details»
ParAllele BioScience, Inc. (ParAllele BioScience, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Ronaghi has also co-founded multiple companies, including Avantome, NextBio, ParAllele Bioscience, and Pyrosequencing. About Seer Seerโข is a life sciences company focused on โฆSee details»
Affymetrix acquires ParAllele BioScience | Drug Discovery News
Jul 26, 2005 In a move that is expected to boost both its GeneChip technology and the assays available for its chips, Affymetrix recently acquired ParAllele BioScience, a privately held, โฆSee details»
ParAllele inks licensing deal for genotyping tech
Jul 6, 2005 ParAllele BioScience has inked a deal with Merck to use its genotyping technology to track the genetic variations that influence a person's susceptibility to cancer and their โฆSee details»
How Parallel Bio aims to turn drug development on its head
Jan 7, 2023 DiFazio has a Ph.D. in immunology of infectious disease and ran drug discovery programs at Stanford. Hilliard has a masters in molecular bioengineering from the Technical โฆSee details»
ParAllele Bioscience - Tech Stack, Apps, Patents & Trademarks
Organization. ParAllele Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Active Tech Count 27. About. ParAllele Bioscience is โฆSee details»
Parallel Bio is putting the immune system in a dish to improve โฆ
Aug 30, 2021 Parallel Bio isnโt replicating the entire human circulatory system in a dish, DiFazio said. Instead, it's modeling the โhome of the immune system,โ namely the lymph nodes and โฆSee details»
Harmony Biosciences Names Adam Zaeske as Chief Commercial
14 hours ago Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands. March 25 ... Zaeske will be โฆSee details»